ArticleMolecular cancer therapeutics2018

Cotargeting the Cell-Intrinsic and Microenvironment Pathways of Prostate Cancer by PI3Kα/β/δ Inhibitor BAY1082439.

Yongkang Zou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.